This announcement is a separate document:
中國抗體-B：截至二零二二年十二月三十一日止年度全年業績公告；所得款項用途變動；及公司秘書變動
SINOMAB BIO-B: ANNUAL RESULTS ANNOUNCEMENTFOR THE YEAR ENDED 31 DECEMBER 2022;CHANGE IN USE OF PROCEEDS;ANDCHANGE OF COMPANY SECRETARY
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.